Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John H Strickler
Academic and Community Cancer Research United
Study Chair - Jorge Ramos, DO
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cliniques Universitaires Saint Luc
Brussels, Other, Belgium
- Universitair Ziekenhuis Antwerpen
Edegem, Other, Belgium
- Uz Leuven Campus Gasthuisberg
Leuven, Other, Belgium
- Hospitalier Jean Minjoz
Besançon, Other, France
- Center Georges Francois Leclerc
Dijon, Other, France
- Hôpital Franco-Britannique - Fondation Cognacq-Jay
Levallois-Perret, Other, France
- Centre Leon Berard - Centre Regional de Lutte Contre Le Cancer Rhone-Alpes
Lyon, Other, France
- Hopital Saint-Antoine
Paris, Other, France
- Instituto Europeo Di Oncologia
Milan, Other, Italy
- Niguarda Ca' Granda Hospital
Milan, Other, Italy
- Azienda Ospedaliero-Universitaria Pisana - Ospedale S. Chiara
Pisa, Other, Italy
- Hospital Universitario Vall D'Hebron
Barcelona, Other, Spain
- Institut Catala D'Oncologia - Hospital Duran I Reynals (ico L'Hospitalet)
L'Hospitalet de Llobregat, Other, Spain
- Hospital General Universitario Gregorio Maranon
Madrid, Other, Spain
- Hospital Clinico Universitario de Valencia
Valencia, Other, Spain
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- Pacific Shores Medical Group
Long Beach, California, United States
- Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California, United States
- Keck Medical Center / University of Southern California
Los Angeles, California, United States
- Stanford University School of Medicine
Palo Alto, California, United States
- Saint Joseph Heritage Medical Group
Santa Rosa, California, United States
- Rocky Mountain Cancer Centers - Aurora
Aurora, Colorado, United States
- Lombardi Cancer Center / Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Florida Cancer Specialists - South Region
Fort Myers, Florida, United States
- Florida Cancer Specialists - North Region
St. Petersburg, Florida, United States
- Winship Cancer Institute / Emory University School of Medicine
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Cancer Center
Westwood, Kansas, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Karmanos Cancer Institute / Wayne State University
Detroit, Michigan, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jun 2017
- Primary completion
- 28 Mar 2022
- Completion
- 2 Nov 2023
- Last update posted
- 26 Nov 2024
- Registered enrollment
- 117
- Registry id
- NCT03043313
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.